Acrodermatitis continua Hallopeau successfully treated by risankizumab

Int J Dermatol. 2021 Apr;60(4):e144-e145. doi: 10.1111/ijd.15391. Epub 2020 Dec 23.

Authors

Jan Hugo¹, Petra Gkalpakioti¹, Monika Arenbergerova¹, Petr Arenberger¹, Spyridon Gkalpakiotis¹

Affiliation

¹ Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic.

PMID: 33368238
DOI: 10.1111/ijd.15391

No abstract available

Publication types

Letter

MeSH terms

Acrodermatitis* / drug therapy
Antibodies, Monoclonal / therapeutic use
Humans
Psoriasis* / drug therapy
Skin Diseases, Vesiculobullous*

Substances

Antibodies, Monoclonal
risankizumab

Grants and funding

Charles University, Prague, Czech Republic.